New Amsterdam Pharma
Jacqueline Shehata PharmD, BCPS serves as the Executive Director and Head of Field Medical at NewAmsterdam Pharma since January 2024. Prior to this role, Jacqueline held the position of Executive Director, Head of Field Medical at Ionis Pharmaceuticals, Inc., where responsibilities included leading and developing Field Medical Directors and launching the drug inotersen (Tegsedi®) for hereditary transthyretin amyloidosis. Jacqueline's earlier experience comprises roles such as Senior Medical Science Liaison at Akebia Therapeutics, Medical Science Liaison at La Jolla Pharmaceutical Company, and Global Medical Training Manager at Mallinckrodt Pharmaceuticals, where notable achievements included receiving the “MSL Team Excellence Award” and the “MSL Colleague of the Year Award.” Jacqueline’s clinical foundation includes experience as a Clinical Pharmacist at Kaiser Permanente and as a Renal Clinical Pharmacist within the Department of Veterans Affairs, where pioneering efforts led to improved clinical outcomes and cost savings. Jacqueline earned a Doctor of Pharmacy degree from Auburn University and a Bachelor of Business Administration in Marketing from the University of Kentucky.
This person is not in any teams
This person is not in any offices
New Amsterdam Pharma
1 followers
Founded in 2019 by the venture capital firm Forbion and John Kastelein, NewAmsterdam Pharma is a privately held, clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies are not tolerated or have been unsuccessful.